Patents matching “treatment”

US 6270979

Methods for anti-addictive narcotic analgesic treatments

The Regents of the University of California · Granted Aug 7, 2001 · Expires Aug 2, 2021

US 6268383

Substituted aromatic compounds for treatment of antibiotic-resistant infections

The United States of America as represented by the Secretary of the Army · Granted Jul 31, 2001 · Expires Jul 26, 2021

US 6261555

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Jul 17, 2001 · Expires Jul 12, 2021

US 6262120

GABA and L-glutamic acid analogs for antiseizure treatment

Northwestern University · Granted Jul 17, 2001 · Expires Jul 12, 2021

US 6255345

GABA and L-glutamic acid analogs for antiseizure treatment

Northwestern University · Granted Jul 3, 2001 · Expires Jun 28, 2021

US 6254869

Cryptopain vaccines, antibodies, proteins, peptides, DNA and RNA for prophylaxis, treatment and diagnosis and for detection of cryptosporidium species

The Regents of the University of California · Granted Jul 3, 2001 · Expires Jun 28, 2021

US 6251396

Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein

Neurocrine Biosciences, Inc. · Granted Jun 26, 2001 · Expires Jun 21, 2021

US 6251861

Treatment of cerebral infarction using cyclic hexapeptides

Takeda Chemical Industries Ltd. · Granted Jun 26, 2001 · Expires Jun 21, 2021

US 6248528

Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders

The Regents of the University of California · Granted Jun 19, 2001 · Expires Jun 14, 2021

US 6245362

Medication for treatment of viral disease based on active agents of plant hypericum (St. John's Wort) and method of production of the medication

Dreluso Pharmazeutika Dr. Elten & Sohn GmbH · Granted Jun 12, 2001 · Expires Jun 7, 2021

US 6242473

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Jun 5, 2001 · Expires May 31, 2021

US 6242482

Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure

United Therapeutics Corporation · Granted Jun 5, 2001 · Expires May 31, 2021

US 6228873

Method for enhancing outflow of aqueous humor in treatment of glaucoma

The Regents of the University of California · Granted May 8, 2001 · Expires May 3, 2021

AU 7932800

Treatment of fatigue, head injury and stroke

AMARIN NEUROSCIENCE LTD · Granted Apr 23, 2001 · Expires Apr 18, 2021

US 6218437

Treatment and prevention of hepatic disorders

The Regents of the University of California · Granted Apr 17, 2001 · Expires Apr 12, 2021

US 6210680

Method for the prevention and treatment of chronic venous insufficiency

Univera Pharmaceuticals, Inc. · Granted Apr 3, 2001 · Expires Mar 29, 2021

US 6207159

Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus

The Regents of the University of California · Granted Mar 27, 2001 · Expires Mar 22, 2021

US 6204245

Treatment of narcolepsy with immunosuppressants

The Regents of the University of California · Granted Mar 20, 2001 · Expires Mar 15, 2021

US 6200597

Formulation and use of carotenoids in treatment of cancer

The Board of Regents of the University of Texas System · Granted Mar 13, 2001 · Expires Mar 8, 2021

US 6197345

Thrombolytic agents and methods of treatment for thrombosis

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 6, 2001 · Expires Mar 1, 2021

US 6197926

Methods for treatment of diabetes using peptide analogues of insulin

Neurocrine Biosciences, Inc. · Granted Mar 6, 2001 · Expires Mar 1, 2021

US 6187814

Treatment of skin conditions with FXR activators

The Regents of the University of California · Granted Feb 13, 2001 · Expires Feb 8, 2021

US 6187296

Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease

The Board of Regents of the University of Oklahoma · Granted Feb 13, 2001 · Expires Feb 8, 2021

US 6184215

Treatment of skin conditions with oxysterol activators of LXR.alpha.

The Regents of the University of California · Granted Feb 6, 2001 · Expires Feb 1, 2021